Skip to main content
SpringerLink
Log in

Japan PMDA's investigation results

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. including Oronine H, Stericlon, Preser S, Tamuchinki Powder Spray C and Shinogi D products.

  2. including amoxicillin alone [Sawacillin, Pasetocin, among others]; amoxicillin/clavulanic acid [Augmentin, Clavamox]; amoxicillin/clarithromycin/lansoprazole [Lansap]; amoxicillin + lansoprazole + metronidazole [Lampion Pack]; amoxicillin + clarithromycin + rabeprazole [Rabecure Pack]; amoxicillin + metronidazole + rabeprazole [Rabefine Pack]; amoxicillin + clarithromycin + vonoprazan [Vonosap Pack]; and amoxicillin + metronidazole + vonoprazan [Vonopion Pack].

References

  1. Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Levetiracetam. Internet Document : [2 pages], 17 Oct 2017. Available from: URL: http://www.pmda.go.jp/files/000220557.pdf.

  2. Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Chlorhexidine gluconate or products containing chlorhexidine hydrochloride (Prescription drugs). Internet Document : [4 pages], 17 Oct 2017. Available from: URL: http://www.pmda.go.jp/files/000220558.pdf.

  3. Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Products containing chlorhexidine gluconate or products containing chlorhexidine hydrochloride (OTC drugs). Internet Document : [4 pages], 17 Oct 2017. Available from: URL: http://www.pmda.go.jp/files/000220559.pdf.

  4. Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Linagliptin. Internet Document : [1 page], 17 Oct 2017. Available from: URL: http://www.pmda.go.jp/files/000220560.pdf.

  5. Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Products containing amoxicillin hydrate. Internet Document : [8 pages], 17 Oct 2017. Available from: URL: http://www.pmda.go.jp/files/000220561.pdf.

  6. Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Moxifloxacin hydrochloride (oral dosage form). Internet Document : [2 pages], 17 Oct 2017. Available from: URL: http://www.pmda.go.jp/files/000220575.pdf.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Japan PMDA's investigation results. Reactions Weekly 1676, 2 (2017). https://doi.org/10.1007/s40278-017-37990-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-37990-3

Search

Navigation